The Role of Gemtuzumab 4.5 mg in Precision Oncology

\n\nGemtuzumab 4.5 mg is a monoclonal antibody that targets CD33 antigen, which is found on the surface of leukemia cells. In precision oncology, this drug has been used to treat patients with acute myeloid leukemia (AML) who are deemed appropriate for this therapy. It has been shown to increase sur

1 views • 3 slides